Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Prostatic Diseases" patented technology

Pathological processes involving the PROSTATE or its component tissues.

Medicine for adjunctively treating prostatic disease

InactiveCN102178808AImprove daily symptomsMale function repair and improvementHydrocarbon active ingredientsInorganic active ingredientsSide effectLycopene
The invention provides a medicine for adjunctively treating prostatic diseases, which is a medicament prepared from the following raw materials and pharmaceutically acceptable auxiliary materials in parts by weight: 160-260 parts of sabal extracts, 25-72 parts of pygeum topengii extracts, 20-80 parts of pumpkinseed extracts, 3-20 parts of lycopene and 2-15 parts of zinc. The medicine is used for treating the prostatic diseases by taking the sabal extracts and the pygeum topengii extracts as main raw materials; the synergistic effect is enhanced through the pumpkinseed extracts to play an important role in enhancing the bioavailability of the effectively components of the sabal extracts; the antioxidant ability of organisms and the resistance can be enhanced through the lycopene; and the risks of prostatic cancers is reduced by preventing and improving the prostatic diseases through the lycopene and the zinc; the medicine provided by the invention accords with the traditional Chinese medicine theory and has more scientific formula and more outstanding effect; through clinical verification, the medicine has better curative effect on the prostatic diseases; in addition, the medicine provided by the invention can be taken for a long time without toxic side effect and has the effects of disease prevention and treatment.
Owner:WUHAN JINJUYE BIOTECH

Ultrasonic treatment unit for prostatic disease

The invention discloses an ultrasonic treatment unit for prostatic diseases, which comprises a spherical crown body, an ultrasonic probe arranged at the bottom of the spherical crown body, an installation base, a spherical crown body support, a spherical crown body support lifting mechanism, a spherical crown body support rotating mechanism, a spherical crown body swing mechanism and an ultrasonic probe lifting mechanism, wherein the spherical crown body support lifting mechanism is installed on the installation base, the spherical crown body support and the spherical crown body support rotating mechanism are installed on the spherical crown body support lifting mechanism, and the spherical crown body swing mechanism and the ultrasonic probe lifting mechanism are installed on the spherical crown body support. Through the linkage of the spherical crown body support lifting mechanism, the spherical crown body support rotating mechanism, the spherical crown body swing mechanism and a spherical crown body rotary mechanism, the spherical domain of the spherical crown body of the ultrasonic treatment unit for prostatic diseases is realized. The invention has the advantages that the structure is compact, the occupied area is small and great progress is made in the ultrasonic treatment unit for prostatic diseases.
Owner:深圳蓝影医学科技股份有限公司

Phytosterol tablet and preparation method thereof

The invention relates to the technical field of health-care products, in particular to a phytosterol tablet. The phytosterol tablet is prepared from the following raw materials in weight ratio: 385.56 parts of phytosterol, 51 parts of dextrin, 32.64 parts of starch, 69.9 parts of sodium carboxymethyl starch, 104.04 parts of povidone, 12.38 parts of magnesium stearate and 2.45 parts of lactose, wherein the weight-average relative molecular weight of the povidone is 2000. A preparation method for the phytosterol tablet comprises the following steps of: evenly mixing all raw materials to obtain a mixture; spraying a mixed solution of an ethanol solution and a hydroxypropyl methylcellulose solution to moist the mixture; pelletizing; drying; performing intermediate inspection; performing granule shaping; and tableting. The phytosterol tablet has the advantages that the dissolving-out speed of the active principle is high; the dissolubility is high; the bioavailability is high; the action of the phytosterol can be better performed; and the medication cost is reduced. The phytosterol tablet is most effective in assisting on reducing blood fat, and meanwhile, also has effects of controlling prostatic diseases and regulating immunity and growth and has an anti-cancer effect, an anti-inflammatory effect and an antiviral effect.
Owner:SHANDONG YIBAO BIOLOGICS

Ultrasonic treatment unit for prostatic disease

The invention discloses an ultrasonic treatment unit for prostatic diseases, which comprises a spherical crown body, an ultrasonic probe arranged at the bottom of the spherical crown body, an installation base, a spherical crown body support, a spherical crown body support lifting mechanism, a spherical crown body support rotating mechanism, a spherical crown body swing mechanism and an ultrasonic probe lifting mechanism, wherein the spherical crown body support lifting mechanism is installed on the installation base, the spherical crown body support and the spherical crown body support rotating mechanism are installed on the spherical crown body support lifting mechanism, and the spherical crown body swing mechanism and the ultrasonic probe lifting mechanism are installed on the spherical crown body support. Through the linkage of the spherical crown body support lifting mechanism, the spherical crown body support rotating mechanism, the spherical crown body swing mechanism and a spherical crown body rotary mechanism, the spherical domain of the spherical crown body of the ultrasonic treatment unit for prostatic diseases is realized. The invention has the advantages that the structure is compact, the occupied area is small and great progress is made in the ultrasonic treatment unit for prostatic diseases.
Owner:深圳蓝影医学科技股份有限公司

Production process of prostatic disease treating particles

The invention discloses a production process of prostatic disease treating particles. The production process comprises an extraction step and a preparation step, wherein the extraction step comprises the following specific steps of: picking each medicinal material, weighing each medicinal material according to parts by weight, and washing motherwort herb, polygonum aviculare and safflower which are required to be washed to a clean state in boiler batch in a spraying way with a medicament washing machine; and putting all of five medicinal materials belonging to the same extraction boiler batch into a multifunctional extraction tank for extracting to obtain a liquid medicament, sucking the liquid medicament into a single-effect vacuum concentrating tank, and concentrating in vacuum to obtain clear paste; and the preparation step comprises the following steps of: putting the weighed extract powder and rape bee pollen into a trough type mixing machine, mixing for 8-12 minutes, adding ethanol of which the volume concentration is 85 percent, stirring for 3-7 minutes, and preparing a soft material. The production process has the advantages of simple Chinese medicinal components, good extraction effect, mild reaction conditions and short reaction time. A preparation provided by the invention is used for treating prostatitis and prostatoplasia, and has a remarkable curative effect.
Owner:JIANGSU CHENPAI PHARM GRP CO LTD

Pill for treatment of prostatic diseases and preparation method thereof

The invention relates to the medical health field, in particular to a pill for the treatment of prostatic diseases and a preparation method thereof. The pill for the treatment of the prostatic diseases is prepared from aristolochia cinnabarina, rhizoma cimicifugae, actinolite, dianthus superbus, juncus effusus, curcuma zedoary, radix aconiti carmichaeli, chingma abutilon seed, lindernia antipoda, honeycomb, indigo naturalis, radix stemonae, common fenugreek seeds, gorgon euryale seed, fiveleaf akebia fruits, paniculate swallowwort root, mulberry, semen cassiae, cassia twig, Chinese yam, poria cocos, cortex moutan, rhizoma anemarrhenae, fritillary, garden balsam stems, herba epimedii, radix angelica sinensis, shixiao powder and portulaca oleracea. The preparation method includes the following steps: taking all the materials, mixing all the materials evenly, decocting the materials with 6-10 fold water for 2-4 hours three times, mixing decocted fluid, filtering the fluid, collecting filtrate, concentrating the collected filtrate into extract, adding auxiliary materials or excipients used for forming a preparation, and preparing all the materials into the pill. The pill for the treatment of the prostatic diseases takes effects quickly, is convenient to take, and has no side effects.
Owner:张超英

Methods and devices for detecting non-complexed prostate specific antigen

InactiveUS7015005B2Interfere with removalSufficient amountBiological material analysisBiological testingΑ1 antichymotrypsinImmunoprecipitation
The present invention relates to novel methods and devices for detecting non-complexed prostate specific antigen (PSA), which can be used either alone or in conjunction with total PSA tests to identify patients having either benign prostatic diseases (BPD), such as benign prostatic hyperplasia, prostatitis, or glandular atrophy or prostatic adenocarcinoma (CAP). In a biological sample, one can find not only non-complexed PSA, but also PSA which has formed a complex with α1-antichymotrypsin (ACT). The present invention removes or precipitates complexed PSA (PSA-ACT) and ACT from a fluid sample, thereby removing any possible interference due to the binding of complexed PSA to assay reagents. The method requires contacting a biological fluid sample possibly containing a mixture of complexed PSA and non-complexed PSA either with an immuno-precipitating reagent or a device having attached an ACT specific binding partner which in both cases specifically binds only to ACT and the ACT portion of complexed PSA, thereby precipitating ACT and the bound complexed PSA and, thus, leaving any non-complexed PSA unbound and in solution. Then, the sample is measured for non-complexed PSA by means of a conventional specific binding reaction. The device can be a filter having a modified filter media that binds ACT and complexed PSA, while permitting the sample to flow or be pulled through the filter media and into assay reagents. Alternatively, the device can be a removable media that is placed into a sample, allowed to remain long enough to bind any ACT and complexed PSA present, and then withdrawn from the sample prior to running a PSA specific binding assay.
Owner:SCANTIBODIES LAB

Tea formula for treating prostatic diseases and preparation method

PendingCN113413425AAdjust drinking tasteRealize anti-virusDispersion deliveryAntipyreticGreen teasRed bean
The invention discloses a tea formula for treating prostatic diseases and a preparation method, and belongs to the technical field of tea formulae. The tea formula specifically comprises the following components in parts by weight: 18-23 parts of Liangwang tea, 12-17 parts of adiantum capillus-veneris, 8-12 parts of green tea, 8-12 parts of prinsepia utilis royle, 45-65 parts of brown sugar, 5-15 parts of red beans, 10-12 parts of fructus choerospondiatis and 8-12 parts of glossy privet fruits. The Liangwang tea and the adiantum capillus-veneris have the effects of clearing away heat and toxic materials, diminishing inflammation, inducing diuresis and treating stranguria. Tea substitute drinking liquid for universally diminishing inflammation on prostate diseases is prepared through cooperation of multiple raw materials, the tea substitute drinking liquid is free of toxic and side effects, the drinking taste is similar to that of tea, and the drinking comfort is improved. The plant enzyme property in the raw material liquid is prevented from being damaged through low-temperature cold-brewing filtration, full precipitation of the raw material liquid medicine is effectively improved through multi-stage extraction and squeezing, the evaporation waste of the medicine property caused by multiple boiling is reduced, the raw material coking caused by heating extraction is avoided, and the drinking taste of the tea substitute is improved.
Owner:田兴元
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products